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ABSTRACT
Any profound comprehension of gene function re-
quires detailed information about the subcellu-
lar localization, molecular interactions and spatio-
temporal dynamics of gene products. We developed
a multifunctional integrase (MIN) tag for rapid and
versatile genome engineering that serves not only
as a genetic entry site for the Bxb1 integrase but
also as a novel epitope tag for standardized detection
and precipitation. For the systematic study of epi-
genetic factors, including Dnmt1, Dnmt3a, Dnmt3b,
Tet1, Tet2, Tet3 and Uhrf1, we generated MIN-tagged
embryonic stem cell lines and created a toolbox of
prefabricated modules that can be integrated via
Bxb1-mediated recombination. We used these func-
tional modules to study protein interactions and their
spatio-temporal dynamics as well as gene expres-
sion and specific mutations during cellular differenti-
ation and in response to external stimuli. Our genome
engineering strategy provides a versatile open plat-
form for efficient generation of multiple isogenic cell
lines to study gene function under physiological con-
ditions.
INTRODUCTION
In the last decades targeted gene disruption has been a
widely used approach to gain first insights into gene func-
tion. However, gene disruption studies are often hampered
by high functional redundancy in mammalian systems and
yield little information about the subcellular localization,
interactions and spatio-temporal dynamics of gene prod-
ucts. In order to gain comprehensive understanding of
gene function these studies need to be complemented by
more complex genetic manipulations such as fluorophore
knockin, specific domain deletions or introduction of point
mutations. Additionally, a systematic analysis of gene func-
tion requires application of biochemical as well as imag-
ing techniques, which usually rely on the generation of
gene specific antibodies, a technically demanding and time-
consuming process.
Recently, RNA guided endonucleases (RGENs) derived
from the prokaryotic Type II CRISPR/Cas (clustered
regularly interspaced short palindromic repeats/CRISPR-
associated) system have emerged as promising tools for the
manipulation and modification of genetic sequences (1–4).
The specificity of RGENs is mediated by small guide
RNAs (gRNAs) that bind to 20 bp within the target se-
quence and recruit the Cas9 nuclease to introduce a dou-
ble strand break. Although this two-component system
has greatly facilitated the generation of gene disruptions in
bacteria, plants and mammals, concerns have been raised
about considerable off-target effects (5–7). Furthermore,
the low frequency of homologous recombination in mam-
mals makes insertion of exogenous components such as flu-
orophore tags difficult and time-consuming.
In addition to RGENs, phage-derived serine integrases
have received considerable attention as novel tools for
genome engineering. Recently, Bxb1 was shown to have the
highest accuracy and efficiency in a screen of fifteen candi-
date serine integrases tested in mammalian cells (8). Serine
integrases are unidirectional, site-specific recombinases that
promote the conservative recombination between phage at-
tachment sites (attP) and bacterial attachment sites (attB)
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(9) with much higher recombination efficiencies (up to 80%)
than the commonly used bidirectional tyrosine integrases,
Cre or Flp (9–12).
In this study, we aim to combine the advantages of both
RGENS and unidirectional integrases into one fast, widely
applicable and flexible method. We developed a novel strat-
egy for genome engineering based on a CRISPR/Cas as-
sisted in-frame insertion of an attP site, which we refer to
as the multifunctional integrase (MIN) tag. At the genetic
level, the MIN-tag serves as an attachment site for the serine
integrase Bxb1 that can be used to introduce a broad range
of prefabricated functional cassettes into the genomic locus
with high specificity and efficiency. At the protein level, the
MIN-tag functions as a novel epitope tag that can be de-
tected with a highly specific monoclonal antibody and used
for immunoprecipitation as well as immunofluorescence ex-
periments. To demonstrate the versatility of the strategy, we
generated MIN-tagged murine embryonic stem cell (mESC)
lines for a variety of major epigenetic factors, including
Dnmt1, Dnmt3a, Dnmt3b, Tet1, Tet2, Tet3 and Uhrf1. We
created a toolbox of vectors for Bxb1-mediated recombina-
tion to generate isogenic cell lines harboring knockout cas-
settes, fluorescent protein fusions, enzymatic tags and spe-
cific mutations; all derived from a single entry cell line en-
suring maximal biological comparability. We demonstrate
the power of this strategy using proximity-dependent pro-
tein labeling to identify novel interactors of TET1 in mESCs
as well as to systematically study the subcellular localiza-
tion, binding kinetics and protein expression dynamics of
the de novo methyltransferase DNMT3B during epiblast
differentiation.
MATERIALS AND METHODS
Western blotting and immunoprecipitation
Western blot analysis was performed using the follow-
ing primary antibodies: anti-DNMT1, anti-DNMT3a (Im-
genex, 64B1446); anti-DNMT3b (Abcam, 52A1018); anti-
UHRF1 (13); anti-TET1, anti-TET2 and anti-TET3 (14);
anti-GFP antibody (Roche, 11814460001); anti--Actin
(Sigma, A5441); anti-SNF2H (Abcam, ab22012). Blots
were probed with anti-rat (Jackson ImmunoResearch,
112-035-068), anti-mouse (Sigma, A9044) and anti-rabbit
(Biorad, 170–6515) secondary antibodies conjugated to
horseradish peroxidase (HRP) and visualized using an ECL
detection kit (Pierce). An anti-mouse antibody conjugated
to Alexa 488 (Life Technologies, A21202) was used for fluo-
rescence detection of western blots using the Typhoon 9400
(GE Healthcare) imaging system.
For immunoprecipitation, ∼1 × 106 Dnmt1attP/attP,
Dnmt3battP/attP or wt cells were harvested in ice cold phos-
phate buffered saline (PBS), washed twice and subsequently
homogenized in 200 l lysis buffer (20 mM Tris/HCl pH
7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 0.5%
NP40). After centrifugation (10 min, 14 000 g, 4◦C) the
supernatant was adjusted with dilution buffer (20 mM
Tris/HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM
PMSF) to a final volume of 300 l. A total of 50 l were
mixed with sodium dodecyl sulphate (SDS)-containing
sample buffer (referred to as input (I)). For pull-downs,
100 l (4 g) of either 5A10 DNMT1 antibody (15) or
the newly generated MIN-tag antibody 1E1 was added to
the cell lysates and incubated 2 h at 4◦C. For pull-down
of immunocomplexes, 40 l of protein G agarose beads
(GE Healthcare, Freiburg, Germany) equilibrated in dilu-
tion buffer were added and incubation continued for 2 h.
After centrifugation (2 min, 5000 × g, 4◦C) 50 l of the su-
pernatant was collected (referred to as flow-through (FT))
while the remaining supernatant was removed. The beads
were washed twice with 1 ml dilution buffer containing 300
mM NaCl. After the last washing step, the beads were re-
suspended in 50 l Laemmli buffer and boiled for 10 min
at 95◦C. For immunoblot analysis, 3% of the input and
the flow-through as well as 30% of the bound (B) frac-
tion were separated on a 10% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and sub-
jected to western blot analysis.
Immunofluorescence staining and microscopy
Immunostaining was performed as described previously
(16). Briefly, cells cultured on coverslips were fixed with
4% paraformaldehyde for 10 min, washed with PBST (PBS,
0.02% Tween20) and permeabilized with PBS supplemented
with 0.5% Triton X-100. Both primary and secondary an-
tibody were diluted in blocking solution (PBST, 2% BSA,
0.5% fish skin gelatin). Coverslips with cells were incubated
with primary and secondary antibody solutions in dark hu-
mid chambers for 1 h at RT; washings after primary and
secondary antibodies were done with PBST. Following sec-
ondary antibody incubations, cells were post-fixed with 4%
paraformaldehyde for 10 min. For DNA counterstaining,
coverslips were incubated in a solution of DAPI (2 g/ml)
in PBS. Coverslips were mounted in antifade medium (Vec-
tashield, Vector Laboratories) and sealed with colorless nail
polish.
For immunolabeling, the following primary anti-
bodies were used: anti-DNMT1 (15); anti-DNMT3A
(Imgenex, 64B1446); anti-DNMT3B (Abcam, 52A1018);
anti-UHRF1 (13); anti-TET1, anti-TET2 (14); GFP-
Booster ATTO488 (Chromotek). The secondary antibod-
ies were anti-rabbit conjugated to DyLight fluorophore 594
(Jackson ImmunoResearch, 711-505-152), anti-mouse con-
jugated to Alexa 488 (Life Technologies, A21202), anti-rat
conjugated to Alexa 488 (Life Technologies, A21208) or
Alexa 594 (Life Technologies, A21209).
Single optical sections or stacks of optical sections were
collected using a Leica TCS SP5 confocal microscope
equipped with Plan Apo 63×/1.4 NA oil immersion objec-
tive and lasers with excitation lines 405, 488, 561 and 633
nm.
Live cell imaging experiments were performed on an
UltraVIEW VoX spinning disc microscope assembled to
an Axio Observer D1 inverted stand (Zeiss) and using a
63×/1.4 NA Plan-Apochromat oil immersion objective.
The microscope was equipped with a heated environmen-
tal chamber set to 37◦C and 5% CO2. Fluorophores were
excited with 488 nm or 561 nm solid-state diode laser lines.
Confocal image series were typically recorded with 14-bit
image depth, a frame size of 1024 × 1024 pixels and a pixel
size of 110 nm. z-stacks of 12 m with a step size of 1 m
were recorded every 30 min for about 24 h or for the live
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cell series of Dnmt3battP/attP every hour for 60 h. To avoid
photodamage of the cells, the AOTF of the laser was set to
low transmission values of 6–10%. Binning was set to 2×.
Super-resolution microscopy
Super-resolution images were obtained with a DeltaVision
OMX V3 3D-SIM microscope (Applied Precision Imaging,
GE Healthcare), equipped with a 60×/1.42 NA PlanApo
oil objective and sCMOS cameras (Olympus). A z-step
size of 125 nm was used during acquisition. SI raw data
were reconstructed and deconvolved with the SoftWorX 4.0
software package (Applied Precision). FIJI and Photoshop
CS5.1 (Adobe) were used for image processing and assem-
bly.
Antigen preparation, immunization, generation of hybrido-
mas and ELISA screening
For the translated attP peptide, the MIN antigen (attP
peptide) was designed with the following sequence
SGQPPRSQWCTVQT-Cys. Peptides were synthesized,
HPLC purified and coupled to OVA (Peps4LifeSciences-
Anette Jacob; Heidelberg). Lou/c rats were immunized
subcutaneously and intraperitoneally with a mixture of
50 g peptide-OVA, 5 nmol CPG oligonucleotide (Tib
Molbiol, Berlin), 500 l PBS and 500 l incomplete
Freund’s adjuvant. A boost without adjuvant was given
6 weeks after primary injection. Fusion of the myeloma
cell line P3 × 63-Ag8.653 with the rat immune spleen
cells was performed using polyethylene glycol 1500 (PEG
1500, Roche, Mannheim, Germany). After fusion, the
cells were plated in 96 well plates using RPMI1640 with
20% fetal calf serum, penicillin/streptomycin, pyruvate,
non-essential amino acids (Gibco) supplemented by
hypoxanthine-aminopterin-thymidine, (HAT) (Sigma, St
Louis, MO, USA). Hybridoma supernatants were tested
in a solid-phase immunoassay. Microliter plates were
coated with avidin (3 g/ml, Sigma) over night. After
blocking with 2% FCS in PBS, plates were incubated with
biotinylated MIN peptide at a concentration of 0.2 g/ml
in blocking buffer. After washing the plates, the hybridoma
supernatants were added. Bound rat mAbs were detected
with a cocktail of HRP-labeled mouse mAbs against the
rat IgG heavy chains, thus avoiding IgM mAbs (-IgG1,
-IgG2a, -IgG2b (ATCC, Manassas, VA, USA), -IgG2c
(Ascenion, Munich, Germany). HRP substrate conversion
was visualized with ready to use TMB (1-StepTM Ultra
TMB-ELISA, Thermo). MIN-tag clone 1E1 (rat IgG1)
was stably subcloned and further characterized.
A set of 25 rat derived hybridoma supernatants were
tested for specificity against an integrated attP peptide in
the Dnmt1 locus using both western blot analysis and high
content microscopy. Western blots were prepared as men-
tioned previously. Each supernatant was used in a 1:10 dilu-
tion. Blots were probed with an anti-rat secondary antibody
conjugated to HRP.
Cells were prepared for immunofluorescence as described
above, with the exception that cells were fixed on a 96-well
Cell Carrier R© plate (Greiner). Cells in individual wells were
incubated with the various hybridoma supernatants (1:100)
for 1 h. As a secondary antibody, anti-rat conjugated to
Alexa 488 (Life Technologies, A21208) was used. Nuclei
were counterstained using DAPI. Images of stained cells
were acquired automatically with an Operetta high-content
imaging system using a 40× air objective (PerkinElmer).
DAPI and ATTO488 coupled antibodies were excited and
their emissions recorded using standard filter sets. Exposure
times were 10 and 400 ms for DAPI and ATTO488, respec-
tively. All monoclonal antibodies described in this study are
available upon request.
The MIN antibody are available via http://human.bio.
lmu.de/ webtools/MINtool/AB info.html.
DNA methylation analysis
For the analysis of DNA methylation levels, genomic DNA
was isolated using the QIAamp DNA Mini Kit (QIAGEN).
Bisulfite treatment was performed using the EZ DNA
Methylation-GoldTM Kit (Zymo Research Corporation)
according to the manufacturer’s protocol. Subsequently,
the major satellite repeats sequence was amplified using
the primers described in (17). The biotinylated polymerase
chain reaction (PCR) products of the second PCR were an-
alyzed by pyrosequencing (Varionostic GmbH, Ulm, Ger-
many).
Targeting donor and plasmid construction
Plasmid sequences can be found in Supplementary Table
S6. Targeting donor constructs were either synthesized as
ssDNA oligonucleotides (Integrated DNA Technologies)
or produced by amplifying 300 to 200 bp long homology
arms with the respective external and internal primer sets
(Supplementary Table S2). These PCR products of the
5′ and 3′ homology arms were pooled and an overlap
extension PCR with the external primers was performed
to yield the final targeting fragments. The gRNA vector
was synthesized at Eurofins MWG Operon based on
the sequences described (3). The subcloning of targeting
sequences was performed by circular amplification. The
surrogate reporter (pSR) was generated by inserting in vitro
annealed DNA oligos via AsiSI and NruI into pCAG-mCh
(18). eGFP was amplified using the primers eGFP-F and
eGFP-R and sequentially cloned into pCAG-mCh-NruI
linker to generate the pSR construct. Reporters were
generated by subcloning in vitro annealed DNA oligos
containing CRISPR target sites into KpnI and NheI
digested pSR. The attB-GFP-knockin construct was
generated from R6K-NFLAP (19) by ligation free cloning
(20) rearranging the backbone sequences into the artificial
intron and introducing the attB site 5′ of the GFP open
reading frame (ORF), removing its start codon. The
attB-GFP-Poly(A) and attB-mCh-Poly(A) constructs were
created by amplifying the GFP ORF including the stop
codon and SV40 Poly(A) signal from pCAG-eGFP-IB and
inserted into the attB-LAP-tag backbone by ligation free
cloning. The attB-mCh-Poly(A)-mPGK-PuroR construct
was generated by subcloning the mPGK-PuroR sequence
from pPthc-Oct3/4 (21) and ligating it into the EcoRV
site of the attB-mCh-Poly(A) construct. The attB-GFP-
Poly(A)-mPGK-NeoR was produced by first exchanging
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the PuroR in pPthc-Oct3/4 with NeoR from pEGFP-C1
(22) using HindIII. The combined mPGK-NeoR was
then subcloned into the attB-GFP-Poly(A) vector via the
same EcoRV site mentioned previously. The attB-GFP-
Dnmt1cDNA-Poly(A), attB-GFP-Tet1cDNA-Poly(A)
and attB-GFP-Dnmt3b1cDNA-Poly(A) constructs were
generated by inserting the appropriate cDNAs from
constructs reported previously (17,23–24) via AsiSI/NotI
sites into the attB-GFP-Poly(A) and attB-mCh-Poly(A)
vectors respectively. The attB-GFP-Dnmt3b6-Poly(A),
attB-GFP-Tet1-d1–1363-Poly(A), attB-GFP-Tet1-d833–
1053-Poly(A), attB-GFP-Tet1-d833–1363-Poly(A) vectors
were produced via circular amplification with overlap





constructs were created by inserting the Dnmt3b6 and
Dnmt3b1 sequences (from attB-GFP-Dnmt3b6-Poly(A)
and attB-GFP-Dnmt3b1-Poly(A)) using AsiSI/NotI sites
into attB-GFP-Poly(A)-mPGK-NeoR and attB-mCh-
Poly(A)-mPGK-PuroR vectors, respectively.
All constructs described in this study are available via Ad-
dgene or via http://human.bio.lmu.de/ webtools/MINtool/.
Cell culture
J1 ESCs were maintained on gelatin-coated dishes in
Dulbecco’s modified Eagle’s medium supplemented with
16% fetal bovine serum (FBS, Biochrom), 0.1 mM ß-
mercaptoethanol (Invitrogen), 2 mM L-glutamine, 1×
MEM Non-essential amino acids, 100 U/ml penicillin,
100 g/ml streptomycin (PAA Laboratories GmbH), 1000
U/ml recombinant mouse LIF (Millipore) and 2i (1
M PD032591 and 3 M CHIR99021 (Axon Medchem,
Netherlands), referred to as ESC medium. Differentiation
of naive pluripotent stem cells to epiblast-like cells was
performed according to the protocol of (25). Briefly, J1
ESCs were maintained in the ground state in Geltrex (Life
Technologies) coated flasks and cultured in N2B27 (50%
neurobasal medium (Life Technologies), 50% DMEM/F12
(Life Technologies), 2 mM L-glutamine (Life Technolo-
gies), 0.1 mM -mercaptoethanol, N2 supplement (Life
Technologies), B27 serum-free supplement (Life Technolo-
gies) containing 2i and 1000 U/ml LIF 100 U/ml Penicillin-
streptomycin) for at least three passages before differentia-
tion. To differentiate naive ESCs into epiblast-like cells, cells
were replated in N2B27 differentiation medium containing
10 ng/ml Fgf2 (R&D), 20 ng/ml Activin A (R6D) and 0.1×
Knockout Serum Replacement (KSR)(Life Technologies).
Time point 0 h in differentiation time-course experiments
corresponds to the time N2B27 differentiation medium was
added to cells.
Generation of MIN-tagged and Bxb1-mediated knockin cell
lines
To produce MIN-tagged cell lines, 5 × 105 cells were disso-
ciated and seeded in 0.2% gelatin (Sigma-Aldrich) coated
p35 plates. After 3 h, cells were transfected with 2 g of
the MIN-tag donor/homology ssDNA oligo or PCR prod-
uct, 0.5 g gRNA construct, 0.5 g surrogate reporter
construct and 1 g Cas9 using Lipofectamine 3000 (In-
vitrogen) according to the manufacturer’s instructions. For
Bxb1-mediated recombination of attB constructs, 5 × 105
cells were transfected with 1 g pCAG-NLS-HA-Bxb1 ex-
pression plasmid ((26) addgene 51271), 1 g of the respec-
tive attB construct and 0.5 g Bxb1 surrogate reporter.
For both MIN-Tagging and Bxb1-mediated recombina-
tion, cells were dissociated, resuspended in ESC medium
48 h post transfection and then analyzed and sorted with
a FACS Aria II (Becton Dickinson). For MIN-tagging, en-
richment of cells with RGEN activity was accomplished
by single-cell sorting GFP and mCherry positive cells into
96-well plates (Falcon) containing 150 l of ESC medium.
For Bxb1-mediated recombination, cells with Bxb1 activity
were enriched for by single-cell sorting GFP positive cells
into 96-well plates. Alternatively for Bxb1-mediated inte-
gration using antibiotic selection, cells were replated into
p150 plates with ESC medium containing G418 (0.5 mg/ml,
AppliChem) and puromycin (1 g/ml, AppliChem) 48 h
post transfection.
Identification of MIN-tagged and Bxb1-mediated knockin
cell lines with restriction fragment analysis and PCR screen-
ing
After ∼7 days (until colonies were readily visible), plates
from single-cell sortings were screened for colony growth.
Surviving colonies were dissociated and individually re-
plated onto two 96-well plates. Genomic DNA was isolated
from one plate after 2–3 days, while the second plate re-
mained in culture. To identify MIN-tagged clones, the re-
gion surrounding the ATG (or stop codon in the case of
C-terminal tagging) was PCR amplified using the appro-
priate external and screening primers (Supplementary Ta-
ble S2). For restriction fragment analysis, 10 l of these
PCR products were digested with either HincII or SacII
and then analyzed on 1.5% agarose gels. PCRs of positive
clones were confirmed by Sanger sequencing. To screen for
Bxb1-mediated recombiation, we employed a three-primer
PCR strategy using the respective external primers flank-
ing the MIN-tagged locus and an attL-specific primer (Sup-
plementary Figure S3A, Table S2). For Bxb1-mediated in-
tegrations using antibiotic selection, mESC colonies were
picked, dissociated using trypsin and plated into individual
wells on 96-well plates ∼7 days after starting antibiotic se-
lection. Genomic DNA isolation and screening PCRs were
performed as described above. Clones harboring the desired
MIN-tag insertion or Bxb1-mediated integration were ex-
panded, frozen and stored in liquid nitrogen.
All cell lines are available at http://human.bio.lmu.de/
webtools/MINtool/cell lines.html.
Genomic DNA isolation for PCR
Cells were lysed in multi-well plates by the addition of 50 l
lysis buffer (10mM Tris/HCl pH 7.4, 10mM EDTA, 10mM
NaCl, 50g/ml Proteinase K, 1.7 M SDS) per well. The
Plates were subsequently incubated at −80◦C for 15 min,
followed by 3 h at 56◦C. Heat inactivation of Proteinase K
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was performed by incubation at 85◦C for 20 min. The re-
sulting crude DNA lysates were directly subjected to PCR.
BioID
BioID experiments were performed after (27) using ex-
tracted crude nuclei (adapted from (28)) as input material.
In brief, cells were cultured for 48 h with or without ad-
dition of 50 M biotin. Cell pellets (∼4 ×107 cells) were
washed once in buffer A (10 mM HEPES/KOH pH 7.9, 10
mM KCl, 1.5 mM MgCl2) and resuspended in buffer A con-
taining 0.15% NP-40 and 1× protease inhibitor (SERVA).
Samples were homogenized using a pellet pestle. After cen-
trifugation, crude nuclei pellets were washed once with PBS.
Crude nuclei were resuspended in BioID-lysis buffer (0.2%
SDS, 50 mM Tris/HCl pH 7.4, 500 mM NaCl, 1 mM
DTT, 1× protease inhibitor), supplemented with 2% Triton
X-100 and subjected to sonication twice using a Branson
Sonifier 450 (15% amplitude, 0.3 s pulse, 0.6 s pause, total
time 30 s). Samples were diluted 1:1 with 50 mM Tris/HCl
pH 7.4 after the first sonication step. Pulldown of biotiny-
lated proteins was performed overnight at 4◦C with rotation
using M-280 Streptavidin Dynabeads (Life Technologies)
for subsequent mass spectrometry or Streptactin-Superflow
agarose beads (IBA) for SDS-PAGE analysis, respectively.
Beads were washed with wash buffer 1 (2% SDS), wash
buffer 2 (0.1% desoxycholic acid, 1% Triton X-100, 1 mM
EDTA, 500 mM NaCl, 50 mM HEPES/KOH pH 7.5) and
wash buffer 3 (0.5% desoxycholic acid, 0.5% NP-40, 1 mM
EDTA, 500 mM NaCl, 10 mM Tris/HCl pH 7.4) followed
by two washing steps with 50 mM Tris/HCl pH 7.4. For
SDS-PAGE analysis, proteins were silverstained after (29).
Digest of proteins and sample preparation for LC-MS/MS
On-beads digest of proteins was performed as described in
(28). All steps were carried out at room temperature. Beads
were resuspended in 2 M Urea in Tris/HCl pH 7.5, reduced
with 10 mM DTT for 20 min and subsequently alkylated
with 50 mM chloroacetamide for 20 min. A total of 0.25 g
Pierce Trypsin Protease (Thermo Scientific) was added for 2
h. Beads were collected by centrifugation and the resulting
peptide supernatant was further incubated overnight with
addition of 0.1 g trypsin. Peptides were desalted using
StageTips (30).
LC-MS/MS and data analysis
Peptides were reconstituted in 20 l mobile phase A (2% v/v
acetonitrile, 0.1% v/v formic acid) and analyzed by tandem
mass spectrometry using a EASY-nLC 1000 nano-HPLC
system connected to a LTQ Orbitrap Elite mass spectrom-
eter (Thermo Fisher Scientific). About 2–4 l of the pep-
tide mixture were separated onto a PepMap RSLC column
(75 m ID, 150 mm length, C18 stationary phase with 2
m particle size and 100 Å pore size, Thermo Fisher Sci-
entific) and introduced into the mass spectrometer at a flow
rate of 300 nl/min running a gradient from 5 to 35% mo-
bile phase B (98% v/v acetonitrile, 0.1% v/v formic acid).
Ion source and transmission parameters of the mass spec-
trometer were set to spray voltage = 2 kV, capillary tem-
perature = 275◦C. The mass spectrometer was operated in
data-dependent mode, selecting up to 10 precursors from a
MS1 scan (resolution = 60 000) in the range of m/z 250–
1800 for collision-induced dissociation (CID). Singly (+1)
charged precursor ions and precursors of unknown charge
states were rejected. CID was performed for 10 ms using
35% normalized collision energy and the activation q of
0.25. Dynamic exclusion was activated with a repeat count
of one, exclusion duration of 30 s, list size of 500 and the
mass window of ±10 ppm. Ion target values were 1 000 000
(or maximum 10 ms fill time) for full scans and 10 000 (or
maximum 100 ms fill time) for MS/MS scans, respectively.
Raw data were analyzed using MaxQuant Version 1.5.2.8
(31) using the MaxLFQ label free quantification algorithm
(32) and the match-between-runs functionality. UniprotKB
MOUSE.fasta was used as a reference database (33). A
maximum of two missed cleavages and a false discovery rate
of 1% were set as parameters. Oxidation of methionine and
biotinylation were searched as variable modifications and
carbamidomethylation of cysteine residues as fixed modifi-
cation. For statistical analysis, the Perseus software version
1.5.1.6 was used (31). Significance was tested using a two
sided Student’s t-test and a permutation based FDR cal-
culation. GO enrichment analysis was performed with the
Gene Ontology enRIchment anaLysis and visuaLizAtion tool
(GOrilla, (34)). A P-value < 0.01 was considered signifi-
cant.
FRAP
Live cell imaging and FRAP experiments were typically
performed on an UltraVIEW VoX spinning disc mi-
croscope with integrated FRAP PhotoKinesis accessory
(PerkinElmer) assembled to an Axio Observer D1 inverted
stand (Zeiss) and using a 63×/1.4 NA Plan-Apochromat oil
immersion objective. The microscope was equipped with a
heated environmental chamber set to 37◦C. Fluorophores
were excited with 488 nm (exposure time: 400 ms, laser
power: 15%) or 561 nm (exposure time: 450 ms, laser power:
30%) solid-state diode laser lines. Confocal image series
were typically recorded with 14-bit image depth, a frame
size of 256 × 256 pixels and a pixel size of 110 nm. For pho-
tobleaching experiments, the bleach regions, typically with
a diameter of 2 m, were manually chosen to cover the chro-
mocenters. Photobleaching was performed using one itera-
tion with the acousto-optical tunable filter (AOTF) of the
488 nm laser line set to 100% transmission. Typically, 10
pre-bleach images were acquired at a rate of 1 s per time-
point and 60 post-bleach frames were recorded at a rate
of 10 s per timepoint. Data correction, normalization and
quantitative evaluations were performed by automated pro-
cessing with ImageJ (http://rsb.info.nih.gov/ij/) using a set
of newly developed macros followed by calculations in Ex-
cel.
RESULTS
A fast and efficient strategy to generate MIN-tagged genomic
loci
Our novel genome engineering strategy relies on the
CRISPR/Cas-assisted insertion of the MIN-tag sequence
into the open reading frame of a target gene either directly
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downstream of the start codon or upstream of the stop
codon (Figure 1A and Supplementary Figure S2H). Nei-
ther regulatory regions nor gene structure are altered, lead-
ing to preservation of the endogenous expression pattern
and post-transcriptional processing of the gene of interest.
Since epigenetic processes undergo dramatic changes
during early embryonic development and are tightly regu-
lated, we tested the efficacy and versatility of our method
by targeting the DNA modifying enzymes Dnmt1, Dnmt3a,
Dnmt3b, Tet1, Tet2 and Tet3 as well as the chromatin bind-
ing protein Uhrf1 in mESCs (Figure 1D). We generated
targeting donors containing the 48 bp MIN-tag sequence
flanked by short homology arms (200–300 bp for PCR-
based donors or 76 bp for single stranded DNA oligos).
We next designed specific gRNAs to target sequences lo-
cated either in close proximity to or overlapping the start
or stop codon of the respective genes. As scarless inte-
gration of the MIN-tag requires a resistance free selec-
tion strategy we used a surrogate reporter assay to enrich
for cells that express an active Cas9:gRNA complex by
fluorescence-activated cell sorting (FACS) (Figure 1B and
C). In this reporter assay, the target sequence is inserted be-
tween the ORF of mCherry (mCh) and GFP thereby dis-
rupting the reading frame of the fusion. GFP is expressed
only when the target sequence is cleaved by a specific and ac-
tive Cas9:gRNA complex, which causes small, frameshift-
ing insertions or deletions by non-homologous end joining
(NHEJ) restoring the reading frame of the fluorescent pro-
tein (35). For each targeting, we co-transfected mESCs with
a mixture of surrogate reporter construct, gRNA vector,
Cas9 expression plasmid and the specific targeting MIN-
tag donor fragment. After single cell sorting of GFP posi-
tive cells and expansion of the resulting colonies, we isolated
genomic DNA by a fast and simplified in-well lysis proto-
col to screen for positive clones by PCR and analytical re-
striction digest. This allows the identification of hetero- and
homozygous insertions already at this stage (Supplemen-
tary Figure S1D). Combined, all targeting yielded positive
clones with an average efficiency of 3% for homozygous and
1% for heterozygous insertions (Supplementary Table S1).
All targeted genes were expressed normally and subcellular
localization as well as enzymatic activity was not disrupted
in comparison to wild-type (wt) cells (Supplementary Fig-
ures S1 and S2). In addition, the possibility of C-terminal
tagging (see Uhrf1 (C); Figure 1D and Supplementary Fig-
ure S2H) allows the MIN-tag to be used in cases where N-
terminal targeting disturbs protein function.
Taken together, these results demonstrate that the MIN-
tag can efficiently be integrated at precise genomic locations
using a CRISPR/Cas assisted, fluorescence based selection
strategy.
Generation of a highly specific monoclonal antibody recog-
nizing the MIN epitope
Insertion of the MIN-tag into the ORF of target genes
leads to expression of a small peptide that does not occur
in the mammalian proteome (Figure 2A). This unique fea-
ture allowed us to generate a highly specific monoclonal an-
tibody against MIN-tagged proteins. Immunofluorescence
(IF) stainings of a mixed Dnmt1attP/attP and wt culture dis-
tinguished single MIN-tagged cells and colonies from wt
cells, demonstrating the high specificity of the anti-MIN an-
tibody (Figure 2B). Pull-down experiments in Dnmt1attP/attP
cell extracts showed a quantitative enrichment of DNMT1
in the bound fraction (Figure 2C). Furthermore, pull-down
of DNMT3B using the anti-MIN antibody efficiently co-
precipitated SNF2H, a known interactor of DNMT3B, in
protein extracts of Dnmt3battP/attP cells, but not in wt con-
trol extracts (Figure 2D) (36).
Collectively, these data show that the MIN-tag can be uti-
lized as a universal epitope tag for IF and immunoprecip-
itation (IP), thus allowing the investigation of localization
and molecular interactions of MIN-tagged proteins.
Functionalization of MIN-tagged genes by Bxb1-mediated
recombination
To demonstrate the versatility of the MIN-tag as a Bxb1
integration site, we constructed a toolbox of functional
cassettes, which we recombined into the MIN-tagged lo-
cus of the maintenance DNA methyltransferase Dnmt1
(Dnmt1attP/attP). First, we generated a knockout vector car-
rying the attB site directly in front of the ORF of GFP
followed by a stop codon and a polyadenylation signal
(attB-GFP-Poly(A), Figure 3A) that we transfected to-
gether with a codon-optimized Bxb1 expression construct
in the Dnmt1attP/attP cell line. Successful recombination
events were identified by GFP expression and single cells
sorted by FACS (Figure 3B). We designed a multiplex PCR
strategy that takes advantage of the unique attL site gener-
ated by successful recombination to facilitate identification
of positive clones and their zygosity (Figure 3D and Supple-
mentary Figure S3A). PCR screening of sorted clones re-
vealed that the attB-GFP-Poly(A) construct had been suc-
cessfully integrated into both alleles in 13 (56.5%) clones
(Supplementary Table S3). Of those, we examined three
clonal cell lines all of which exhibited no residual expres-
sion of DNMT1 by western blot analysis and IF (Figure
3F; Supplementary Figure S3B and C). For functional char-
acterization, we analyzed DNA methylation levels at major
satellite repeats, one of the main substrates for DNA methy-
lation activity of DNMT1 during replication (37,38). Due
to the loss of the maintenance DNA methyltransferase in
the Dnmt1KO/KO clones, a severe hypomethylation was ob-
served at this sequence (Figure 3E). Taken together, our
attB-GFP-Poly(A) vector proved to be a valuable tool to
generate genetically-defined gene knockouts in MIN-tagged
cell lines.
Second, we designed a GFP knockin construct that can
be used to generate in-frame GFP fusions of MIN-tagged
genes. To avoid disruption of the gene locus and preserve the
endogenous splicing sites, we placed the bacterial backbone
sequences into an artificial intron splitting the GFP ORF
into two exons (19) (Figure 3A). After recombination and
FACS sorting for GFP expressing cells, the GFP knockin
construct integrated in both alleles of the Dnmt1 locus in 13
clones (41.9%), without altering physiological DNMT1 ex-
pression levels (Figure 3G, Supplementary Figure S3D and
Table S3). Live cell imaging of Dnmt1GFP/GFP cells revealed
a normal localization of GFP-DNMT1 throughout the cell
cycle (15,24)(Supplementary Figure S3E), demonstrating
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Figure 1. Generation of MIN-tagged cell lines. (A) Schematic overview of MIN-tag insertion into the Dnmt1 locus via CRISPR/Cas assisted gene editing.
The MIN-tag donor harbors the attP site and homology to the genomic sequence 5′ and 3′ of the start codon. Integration is facilitated by double strand
breaks created by Cas9 directed to the target sequence by a specific gRNA. Restriction enzyme recognition sites used for screening in this study are indicated
above the attP sequence. (B) Schematic overview of the surrogate reporter used to enrich for cells expressing a functional Cas9 complex. The respective Cas9
target sequence (tSeq) is placed downstream of mRFP followed by a stop codon and an out-of-frame GFP ORF. This surrogate reporter is transfected
into the cells together with a vector expressing Cas9 and a U6 driven gRNA expression cassette. (C) Cells that express a functional Cas9 complex can
then be identified by expression of GFP and enriched via FACS. (D) Screening PCRs followed by restriction digest with HincII or SacII of all generated
MIN-tagged cell lines. (N) and (C) refer to N- and C-terminal tagging, respectively.
that DNMT1 regulation was not impaired. Albeit only at
low frequencies, Bxb1 has been shown to damage recom-
bination sites (8). Therefore, we sought to confirm that the
Bxb1-mediated recombination of the GFP cassette at the
MIN-tagged locus occurred without error via site-specific
recombination. We sequenced the region flanking the attL
site in the Dnmt1GFP/GFP cell line (Supplementary Figure
S4) and determined that the GFP cassette was accurately
integrated in a scarless fashion. In summary, this attB-GFP
vector is suited to express GFP fusion proteins from the en-
dogenous promoter preserving physiological regulation and
splicing of the target gene.
Finally, we investigated whether the MIN-tag can be used
to generate cell lines expressing mutants of the target gene
for functional screenings or disease modeling. We cloned
the cDNA of Dnmt1 into the attB-GFP-Poly(A) construct
in-frame with GFP and performed recombination as de-
scribed above. We identified 10 (66.6%) clones in which in-
tegration had occurred, of which 9 (60%) were homozygous
for the Dnmt1 cDNA knockin (Supplementary Table S3).
Expression analysis by western blot and live cell imaging
revealed that the endogenous DNMT1 protein was com-
pletely replaced by the Dnmt1 mini gene product and exhib-
ited normal localization (Figure 3H, Supplementary Figure
S3F).
All in all, we show that MIN-tagged entry cell lines can
be efficiently functionalized with a flexible toolbox of attB-
vectors to generate gene knockouts, N-terminal fusion con-
structs such as GFP and cDNA knockins. In total, we
generated 15 derivatives of our MIN-tagged cell lines so
far. The efficiency of Bxb1-mediated recombination ranged
from 33 to 67%, with an average of 50% (Supplementary
Table S3, Figure S5). This demonstrates the efficacy of our
system as well as the simplicity with which MIN-tagged cell
lines can be modified and functionalized by prefabricated
cassettes. The error-prone step of CRISPR/Cas-mediated
insertion of the MIN-tag is necessary only once to generate
an entry cell line, which can then be specifically manipulated
with a variety of recombination vectors, allowing maximum
biological comparability.
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Figure 2. Application of the anti-MIN monoclonal antibody. (A) DNA sequence of the attP site and corresponding translated MIN peptide sequence
(orange). (B) Fluorescence micrographs of wt mESCs, Dnmt1attp/attp cells and of a mixed culture (1:10) of wt and Dnmt1attP/attP cells stained with
the anti-MIN antibody. DAPI is used as DNA counterstain. Scale bars represent 5 m. (C) IP experiments performed with anti-MIN and anti-DNMT1
antibody in Dnmt1attP/attP cell extracts (input (I), flow through (FT), bound (B)). (D) Co-IP of DNMT3B in wt and Dnmt3battP/attP cells using the
anti-MIN antibody. DNMT3B co-precipitated SNF2H in Dnmt3battP/attP cells as determined by western blot.
Using the MIN-tag strategy to study endogenous protein reg-
ulation
As elucidating the function of uncharacterized protein do-
mains requires systematic analysis, we generated a series
of deletion constructs covering the N-terminus of TET1,
which we aimed to recombine into our Tet1attP/attP cell line
(Figure 4A). However, we were unable to identify positive
recombination events by FACS due to low expression of
this target gene. To circumvent this problem, we developed
a surrogate reporter system for Bxb1 mediated recombina-
tion that can be used to enrich for positive recombination
events (Figure 3C). The Bxb1 surrogate reporter construct
consists of a constitutive promoter followed by an attP site
and a Poly(A) sequence. Upon transfection, Bxb1 mediates
the recombination of a fluorophore (e.g. GFP) containing
attB plasmid with the Bxb1 surrogate reporter, which re-
sults in the expression of GFP. This allows enrichment of
positive recombination events, even when the MIN-tagged
gene is not expressed or only at low levels.
Using the Bxb1 surrogate reporter for enrichment and the
above described PCR strategy for screening, we were able to
generate four Tet1 knockin cell lines expressing N-terminal
deletion constructs from the endogenous promoter. West-
ern blot analysis revealed complete replacement of wt TET1
expression by the knockin constructs (Figure 4B). These cell
lines can be used for future systematic studies of the regu-
latory function of the TET1 N-terminus that is largely un-
known so far.
Taking advantage of the MIN-tag strategy to express fu-
sion constructs at endogenous levels, we expanded our tool-
box to include a BirA* cassette which we knocked into the
Tet1 locus (Supplementary Figure S5G). In contrast to clas-
sical IP approaches, proximity-dependent protein labeling
by the promiscuous biotin ligase, BirA* (BioID) (27), al-
lows the characterization of the full microenvironment of a
protein of interest independent of physical protein–protein
interactions. This technique enabled us to pull down pro-
teins within close proximity (∼10 nm radius, (39)) of TET1
that were subsequently identified by LC-MS/MS (Figure
4C). We found nine proteins to be significantly enriched (40)
upon addition of exogenous biotin to the culture medium of
our Tet1BirA*/BirA* mESC line, including SIN3A, a known
interactor of TET1 (41) (Figure 4D and E). Interestingly,
these proteins are associated with chromatin modification
and organization (Figure 4F). This marks the first time that
the BioID method has been used in mESCs and in a non-
overexpression context with the BirA* ligase fused to the
endogenous protein.
Using the MIN-tag strategy to study dynamic cellular pro-
cesses
During early embryonic development, the epigenome un-
dergoes massive rearrangements that are precisely regu-
lated. Knockout of the major epigenetic factors is often
embryonic lethal (38,42) and over-expression studies fre-
quently fail to reflect the tight regulation of these proteins.
Therefore, more flexible and delicate genetic manipulations
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Figure 3. Bxb1-mediated insertion of functional cassettes into the Dnmt1 locus. (A) Schematic outline of the strategy and vectors used to create knockout,
GFP knockin and cDNA knockin functionalizations of the Dnmt1attP/attP cell line. cDNAs can be cloned into the attB-GFP-Stop-Poly(A) vector using the
8-cutters AsiSI and NotI. (B) FACS plot depicting the gating and sorting of mESCs to enrich for cells positive for integration of the knockout cassette (2.05%
of parent population) based on GFP expression. (C) The Bxb1 surrogate reporter consists of a constitutive CMV promoter followed by an attP site. If Bxb1
and attB donor plasmid containing GFP is present in the cell, recombination of the donor into the reporter leads to expression of GFP. The Bxb1 surrogate
reporter can be used to enrich for successful recombination events by FACS. (D) Gel electrophoresis of the multiplex PCR for wt, Dnmt1attP/attP (attP/attP),
Dnmt1KO/KO (KO/KO), Dnmt1cDNA/cDNA (cDNA/cDNA) and Dnmt1GFP/GFP (GFP/GFP) as well as 1:1 mixtures with Dnmt1attP/attP genomic DNA, to
control for amplification biases. Blue arrows indicate expected sizes of the non-recombined (attP) and recombined allele (attL). (E) DNA methylation
levels at the major satellite repeats of Dnmt1KO/KO cells compared to wt and Dnmt1attP/attP cells. (F) Western blot analysis of DNMT1 expression levels
in wt, Dnmt1attP/attP and Dnmt1KO/KO cells generated by Bxb1-mediated insertion of a knockout cassette. (G) Western blot analysis of DNMT1 and GFP
expression in Dnmt1attP/attP and homozygous GFP-knockin cells (Dnmt1GFP/GFP) generated by Bxb1-mediated insertion. (H) Western blot analysis of
DNMT1 and GFP expression in Dnmt1attP/attP and Dnmt1cDNA/cDNA cells expressing a GFP-Dnmt1 minigene from the endogenous promoter.
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Figure 4. Study of TET1 regulation. (A) Schematic representation of the Tet1 cDNA constructs used for Bxb1-mediated recombination into Tet1attP/attP
cells. (B) Western blot analysis of TET1 expression in Tet1attP/attP cell line and its derivatives expressing GFP-TET11–1363 (1–1363), GFP-TET1833–1053
(1833–1053) and GFP-TET1833–1363 (833–1363). Note that fusion to GFP increases the MW of TET1 constructs by 29 kDa. (C) Schematic represen-
tation of the BioID approach as described by Roux etal. (27). (D) SDS-PAGE analysis of a BioID pulldown experiment using the Tet1BirA*/BirA* cell line.
Cells were cultured either without (control) or with 50 M biotin (+biotin). C: Cytoplasm, I: Crude nuclei input, FT: Flowthrough, B: Bound, W1-W3:
Wash. (E) Volcano plot of proteins identified in the streptavidin pulldown of the TET1-BioID experiment, quantified with the MaxQuant Label-Free-
Quantification algorithm (32). The x-axis reflects the difference in protein abundance in the BioID pull-down compared to the negative control while the
y-axis shows the logarithmized P-value of a student’s t-test. Significantly enriched proteins are highlighted in pink (FDR = 0.01, S0 = 3, indicated by black
line (40)). Experiments were performed in duplicates. (F) GO term enrichment of proteins identified as significant in BioID.
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are needed to study the function of epigenetic factors in vivo.
Here, we focus on the de novo DNA methyltransferase 3B
(DNMT3B), one of the key factors during epiblast differen-
tiation. While it has been shown that DNMT3B, in concert
with DNMT3A and DNMT3L, is responsible for the global
wave of de novo DNA methylation occurring during epiblast
differentiation (42–44), little is known about its localization
and protein kinetics during this developmental time period.
To address this question in a systematic fashion,
we generated a homozygous GFP knockin cell line
(Dnmt3bGFP/GFP) from the Dnmt3battP/attP cell line by Bxb1-
mediated recombination (Figure 5A and 6A). This allowed
us to follow expression of DNMT3B under native regu-
latory conditions and to monitor its localization during
the two-day transition from naive pluripotent ESCs to
Epiblast-like cells (EpiLCs, (25)) using live cell imaging with
high temporal resolution (1 image per hour).
At the naive pluripotent state, we observed very low ex-
pression levels of DNMT3B. Upon addition of differen-
tiation medium, protein expression was strongly and uni-
formly upregulated reaching its maximum at 48–52 h (Fig-
ure 5B, Supplementary video 1). Overall, these findings
were consistent with Dnmt3b mRNA levels in wt and
Dnmt3battP/attP cells (Figure 5C). Interestingly, we observed
a highly dynamic subnuclear distribution of DNMT3B dur-
ing differentiation that can be classified into three patterns
(Figure 5B). (i) In the first 14 h of differentiation, DNMT3B
is expressed at low levels and no clear enrichment is visi-
ble. (ii) Between 14–40 h after initiation of differentiation,
DNMT3B expression is upregulated and accumulates at
constitutive heterochromatin of chromocenters (CCs). (iii)
After 40 h of differentiation, DNMT3B is highly expressed
and localization to CCs is diminished. The above-described
patterns were not related to specific cell cycle stages, in-
dicating a differentiation stage dependent localization of
DNMT3B (Supplementary Figure S6A).
To investigate the specific chromatin distribution of
DNMT3B during differentiation in more detail, we per-
formed super-resolution 3D structured illumination mi-
croscopy (3D-SIM) with the anti-MIN antibody for protein
visualization. DAPI and trimethylated lysine 4 of histone 3
(H3K4me3) were used as markers of heterochromatin and
euchromatin (45), respectively. In agreement with the live
cell imaging experiments, DNMT3B localizes at CCs, clus-
ters of subcentromeric regions, at the 30 h time point and
shows a broader distribution at 60 h after differentiation
(Figure 5D). Interestingly, the higher resolution of 3D-SIM
revealed an accumulation of the signal in facultative hete-
rochromatin at perinuclear and perinucleolar regions at the
60 h time point (Figure 5D; right panel).
DNMT3B has been shown to be responsible for the
methylation of major satellite DNA, a main constituent
of CCs (42,46–47). As DNMT3B is enriched at CCs be-
tween 14–40 h of differentiation, we investigated whether
DNMT3B is actively methylating these sequences during
this period. Therefore, we performed fluorescence recov-
ery after photobleaching (FRAP) of GFP-DNMT3B lo-
calized at CCs. Using our Dnmt3bGFP/GFP cell line, we per-
formed FRAP experiments at 35 h of differentiation. Using
circular regions of interest (ROIs) that encompassed indi-
vidual CCs, we monitored signal recovery for 10 min after
bleaching. We found that the signal exhibited a slow recov-
ery rate (t1/2 = 42 s) and did not recover completely. As
DNA methylation has been shown to have a slow turnover
rate (48,49), this suggested the immobile fraction (∼20%) of
DNMT3B could be catalytically active at CCs (Figure 6B
and D, Supplementary Table S4). To test this hypothesis,
we performed FRAP experiments on cells treated with the
DNA methyltransferase inhibitor 5-aza-2’-deoxycytidine
(5-azadC), which irreversibly traps DNMTs at their site of
action (50). We found that 5-azadC treated CCs exhibited a
large immobile fraction (∼80%) suggesting that DNMT3B
is actively methylating CCs at this time point. However,
we were surprised to find that ∼20% of DNMT3B enzyme
still remained mobile (Figure 6C). Considering the long 5-
azadC treatment time of 12 h this suggested that a fraction
of the enzyme never engaged in catalytic reactions. As our
GFP cassette preserves endogenous splicing patterns, the
GFP-DNMT3B fusions used in this study represent a mix-
ture of different protein isoforms. This prompted us to in-
vestigate the contribution of Dnmt3b splicing isoforms to
the observed FRAP kinetics.
For Dnmt3b, nine splicing isoforms, all originating from
the same translational start site, have been described
(51). Besides the catalytically active isoform DNMT3B1,
DNMT3B6 has been shown to be highly expressed in ESCs.
This isoform is produced by alternative splicing, skipping
exons 23 and 24, resulting in a protein that lacks several
highly conserved motifs within the catalytic domain and has
therefore been suggested to be inactive (52).
To dissect the contributions of DNMT3B1 and
DNMT3B6 to the observed FRAP kinetics of
Dnmt3bGFP/GFP cells, we generated a cell line express-
ing fluorescent fusions of each isoform. For this, we
produced cDNA knockin constructs in which DNMT3B1
was fused to a red fluorescent protein mCherry (mCh) and
DNMT3B6 was fused to GFP. To facilitate the generation
of knockin cell lines expressing each isoform from one allele
we equipped the Dnmt3b1 and Dnmt3b6 constructs with a
Neomycin and Puromycin resistance cassette, respectively.
We successfully established a cell line that simultaneously
expressed mCh-DNMT3B1 and GFP-DNMT3B6, both
under the control of the endogenous Dnmt3b promoter
(Figure 6A, Supplementary Figure S6B), allowing us to
directly compare the FRAP kinetics of DNMT3B1 and
DNMT3B6 within the same cell. In the absence of 5-azadC,
GFP-DNMT3B6 exhibited a fast (t1/2 = 5 s) and complete
recovery while mCh-DNMT3B1 recovered slower (t1/2 =
95 s) (Figure 6B, Supplementary Table S4).
Intriguingly, FRAP kinetics of DNMT3B6 were not in-
fluenced by the presence of 5-azadC, supporting that it
is catalytically inactive. In contrast, DNMT3B1 was com-
pletely immobilized by addition of 5-azadC exhibiting vir-
tually no recovery after photobleaching (Figure 6C and E).
Taken together, our MIN-tag strategy enabled us to show
that DNMT3B exhibits a dynamic localization to distinct
chromatin regions during epiblast differentiation. Super-
resolution micrographs of cells stained with anti-MIN an-
tibodies at different time points of epiblast differentiation
hint towards progression of de novo DNA methylation in
a hierarchical fashion starting at constitutive (CCs) and
progressing towards facultative (perinuclear/perinucleolar)
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Figure 5. Spatio-temporal dynamics of DNMT3B during epiblast differentiation. (A) Gel electrophoresis of the multiplex screening PCR for wt,
Dnmt3battP/attP and Dnmt3bGFP/GFP. Blue arrows indicate expected sizes of the non-recombined (attP) and recombined allele (attL). (B) Evaluation of
GFP signals during live cell imaging of Dnmt3bGFP/GFP cells. The graph depicts mean gray values of nuclear GFP signals. Error bars represent standard
deviations (n > 81). Lower panels show Z-projections of Dnmt3bGFP/GFP cells representative of the indicated time frame. Scale bar represents 10 m. (C)
Quantitative real-time PCR of Dnmt3b mRNA levels in wt and Dnmt3battP/attP cells during epiblast differentiation. (D) 3D-SIM nuclear mid-sections
of anti-MIN (green) and anti-H3K4me3 (red) antibody distributions 30 and 60 h after induction of EpiLC differentiation combined with DAPI coun-
terstaining (gray) in Dnmt3battP/attP cells. Lower panels represent 7× magnifications of selected boxed regions. Scale bars represent 3 m and 500 nm in
insets.
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Figure 6. Protein dynamics of DNMT3B and its isoforms during epiblast differentiation. (A) Schematic representation of the Dnmt3b genomic loci in
the Dnmt3bGFP/GFP and the Dnmt3bmCh-3b1/GFP-3b6 cell lines. (B) Quantitative evaluation of FRAP experiments (average of 11–14 cells) comparing GFP-
DNMT3B with GFP-DNMT3B6 and mCh-DNMT3B1 in Dnmt3bGFP/GFP and the Dnmt3bmCh-3b1/GFP-3b6 cell lines differentiated for 35 h. Error bars
represent standard error of the mean. (C) Quantitative evaluation of FRAP experiments (average of 10–12 cells) as in (B) with cells treated with 5-azadC
12 h before imaging. (D and E) Representative images of FRAP experiments performed in (B) and (C), respectively. White circles indicate the bleach ROI
with a diameter of 2 m.
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heterochromatin. Finally, FRAP experiments revealed that
the two isoforms DNMT3B1 and DNMT3B6 exhibit dra-
matically different DNA binding kinetics.
DISCUSSION
Recent advances in genome engineering technology, based
on TALEN and CRISPR/Cas systems, have greatly facili-
tated the process of manipulating genetic information. Plat-
forms have been established that allow genome-wide gene
disruption screenings for factors involved in any biologi-
cal process (20,53–54). While these methods provide valu-
able information about the genes and pathways involved,
in-depth analysis of target genes is needed to understand
their function. This, in turn, requires the implementation of
various genetic, cell biological and biochemical techniques.
To gain meaningful insights into gene function, these tech-
niques have to be applied under physiological conditions
requiring extensive and complex genetic manipulations. Al-
though modern genome engineering tools have made such
manipulations possible, a more efficient and universal ap-
proach would be highly desirable to implement the above-
mentioned techniques in a systematic manner.
The MIN-tag strategy offers a new means of rapid, ef-
ficient, yet flexible genetic manipulation of target loci. We
show that CRISPR/Cas assisted insertion of the MIN-tag
can be performed efficiently with short homology donors.
Several studies have shown that CRISPR/Cas mediated
gene targeting is associated with a significant risk of off-
target cleavage, which can result in indel (insertions or
deletions) formation due to NHEJ (5–7,55–56). The MIN-
tag strategy requires a single nuclease assisted gene edit-
ing event, thereby keeping the likelihood of off-target ef-
fects at a minimum. Further modifications are then per-
formed using Bxb1-mediated recombination. In contrast to
the phiC31 integrase, Bxb1 has been shown to be highly
specific with virtually no unwanted genomic insertions at
pseudo attP sites (8–9,57–58). Once a MIN-tagged cell line
is established, in-frame fusion of the MIN-tag to the target
gene also results in the expression of a novel epitope tag.
We show that this epitope tag can be detected by a highly
specific antibody, which can be used to screen for posi-
tive clones, perform co-immunoprecipitation (co-IP) exper-
iments, as well as conventional and super resolution mi-
croscopy.
Using Bxb1 and the MIN-tag toolbox, a MIN-tagged en-
try cell line can be used to generate multiple isogenic deriva-
tives within 2–3 weeks (Figure 7), without the risk of in-
troducing off-target effects. Our collection of vectors for
Bxb1 mediated recombination currently contains over 80
different plasmids (Supplementary Table S5). These prefab-
ricated functional cassettes constitute an expandable tool-
box for the simple and flexible genetic alteration of any
tagged loci, without the need of locus-specific homology.
Using our stop cassette, we show that the MIN-tag strat-
egy can be used to reliably achieve genetically defined gene
disruption of MIN-tagged genes. Harboring a Poly(A) sig-
nal, insertion of this cassette efficiently eliminates target
gene expression with the added advantage of precluding un-
wanted downstream initiation. As fluorescent protein re-
porters are commonly used to study spatio-temporal dy-
namics and protein kinetics in living cells, we generated a
GFP knockin construct (attB-GFP) for Bxb1-mediated in-
tegration. GFP knockin cell lines made with this construct
retain not only their endogenous expression levels but also
their endogenous splicing pattern. Similarly, a BirA* cas-
sette can be introduced at any MIN-tagged locus to allow
for proximity-dependent labeling of the microenvironment
of a given protein.
Understanding protein function often necessitates the
systematic alteration of individual domains through muta-
tions as well as deletions. Equipped with a fluorescent pro-
tein and strategic cloning sites, our cDNA knockin cassette
is especially tailored for simple and expedient insertion of
user-defined cDNAs. PCR-based approaches can be used
to easily alter the coding sequence and quickly produce a
library of gene specific cDNA mutants. These can then be
inserted into target loci by Bxb1-mediated recombination,
completely replacing expression of the wt gene while retain-
ing endogenous control. While this strategy does not di-
rectly introduce the mutations into the gene locus, it offers a
means of inserting and testing multiple mutant constructs in
a short time frame without the need to design and perform
additional nuclease-assisted targetings. This feature can be
used to gain insights into the functional implications of the
rapidly growing number of mutations found in cancer and
disease. Likewise, the generation of large deletion mutants is
easily accomplished facilitating the investigation of protein
domain function and interaction mapping. This eliminates
the need for excising large genomic regions or cloning long
site-specific homology donors.
Obviously, the above mentioned plasmids by no means
represent the extent of all possible functional cassettes. For
example, MIN-tag toolbox modules allowing inducible pro-
tein stabilization or localization (59,60) as well as enzymatic
labeling of DNA binding sites (DamID (61)) would greatly
assist the elucidation of protein function and protein-
chromatin interactions, respectively.
Employing our strategy in mESCs, we inserted the MIN-
tag into the genes coding for all mammalian DNA mod-
ifying enzymes and a cofactor (Dnmt1, Dnmt3a, Dnmt3b,
Tet1, Tet2, Tet3 and Uhrf1). These MIN-tagged cell lines
as well as their functional derivatives (Supplementary Ta-
ble S3) constitute a valuable resource to investigate the
role of these proteins during fundamental processes such as
pluripotency, cellular reprogramming, embryonic develop-
ment and disease.
One gold standard method to study protein–protein in-
teractions is co-IP. However, chromatin- or membrane-
bound proteins are often barely soluble and consequently
difficult to investigate by this approach. Making use of our
BirA* cassette, we investigated factors in the microenviron-
ment of TET1, a dioxygenase that oxidizes DNA at methy-
lated cytosines (62). Besides the known interactor SIN3A,
we identify eight other proteins in proximity to TET1 that
are involved in chromatin modification and organization,
including the closely related TET2. This is in accordance
with the findings by Costa et al. (63) that TET1 and TET2
have partially overlapping target sites. In conclusion, inte-
gration of the BirA* cassette into the endogenous locus is
a perfectly suited method to study dynamic protein–protein
interactions.
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Figure 7. The MIN-tag strategy. (A) Schematic outline of the genome engineering strategy. Small homology donors are used to insert serine integrase
(attP) sites in-frame after the ATG codon of target genes via CRISPR/Cas assisted HR. The attP site is translated as a novel epitope tag suitable for IF
and IP with the specific monoclonal antibody. The attP site is also recognized by the serine integrase Bxb1 and used for specific and directional integration
of attB-carrying functional cassettes into the tagged gene locus. All derivatives are subjected to their endogenous gene regulation ensuring that subsequent
studies are performed at physiological expression levels. (B) Timeline for generation of MIN-tagged genes and subsequent modification by Bxb1-mediated
recombination. MIN-tagged cell lines can be generated within 2–3 weeks. These cell lines can then be modified within another 2–3 weeks to generate
multiple isogenic cell lines with different functional modifications.
We also applied the MIN-tag strategy to study the de
novo DNA methyltransferase DNMT3B during the transi-
tion from naive pluripotent ESCs to primed EpiLCs, a pe-
riod of dramatic epigenetic change. While distinct patterns
have been described for ESCs and somatic cells (46,64), the
subnuclear distribution of DNMT3B during differentiation
remains largely unknown. We discovered that DNMT3B
exhibits a highly dynamic subnuclear distribution during
epiblast differentiation. Our observations suggest that the
global wave of de novo DNA methylation during epiblast
differentiation follows a distinct spatio-temporal order, ini-
tiating at constitutive pericentromeric heterochromatin fol-
lowed by transition to facultative heterochromatin.
Exploiting the unique possibilities of our MIN-tag
strategy, we furthermore generated a cell line simultane-
ously expressing differentially tagged splicing isoforms of
DNMT3B from different alleles. This approach revealed
that the major catalytically active isoform DNMT3B1 was
completely immobilized at chromocenters after 5-azadC
treatment, while the FRAP kinetics of DNMT3B6 were not
affected. This, to our knowledge, is the first time that FRAP
has been performed on different isoforms of a protein at en-
dogenous expression levels in the same cell.
While this study was performed using mouse ESCs, our
strategy can be applied to any cell type as long as no Bxb1
attP site is present in the respective genomes. The human
genome is free of this entry site and introduction of the
MIN-tag into cell lines such as human induced pluripo-
tent stem cells should greatly facilitate the generation of
clinically relevant disease models. Moreover, MIN-tagged
mESCs could be used in blastocyst injections to gener-
ate MIN-tagged mice. Different tissues and cells could not
only be used for Bxb1-mediated genetic manipulation in
vitro, free of the limitation posed by inefficient endogenous
homologous recombination, but also to study tissue spe-
cific protein regulation with the MIN-tag antibody. Fur-
thermore, widely used cell biological model systems such as
HeLa and U2OS cells as well as model organisms such as
Caenorhabditis elegans or Drosophila could benefit from the
versatility and efficiency of our approach.
In summary, with our combined genome engineering ap-
proach, a plethora of functional derivatives can be gener-
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ated from one entry line with high efficiency. To simplify
the distribution of MIN-tagged cell lines and the MIN-tag
toolbox as well as to assist with the design of targeting
strategies, we have developed a web-tool that is accessible
at http://human.bio.lmu.de/ webtools/MINtool/. As entry
lines can be shared and the genetic toolbox easily expanded
with new functional modules, the MIN-tag strategy repre-
sents a dynamic flexible open platform and facilitates sys-
tematic functional studies with direct biological compara-
bility.
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